期刊文献+

c-myc反义核酸对乳腺癌MCF-7细胞生长及hTERT基因表达的影响 被引量:4

Effect of c-myc Antisense Oligodeoxynucleotides on Cytology and Human Telomerase Reverse Transcriptase Gene in MCF-7 Cells
暂未订购
导出
摘要 目的探讨脂质体介导c-myc基因反义寡核苷酸(Antisense phosphorothioate oligodeoxynucle-otide,ASODN)对MCF-7细胞生长及其人体端粒酶逆转录酶(humantelomerasereversetranscriptase,hTERT)基因表达的影响。方法将c-myc正、反义寡核苷酸(ODN)分别导入各组MCF-7细胞中,MTT法、逆转录-聚合酶链法及流式细胞术分别检测各组细胞生长情况、hTERTmRNA的表达水平以及细胞凋亡率。结果c-mycASODN转染MCF-7细胞24h后,细胞生长受到抑制(P<0.05),并且hTERTmRNA表达明显降低;随着反义核酸作用时间的延长,凋亡细胞数目逐渐增多,细胞生长及hTERT表达的下降随时间延长逐渐明显。对照组、LR-SODN组、LR-ASODN24h组与LR-ASODN48h、72h组相比有明显统计学差异(P<0.05)。结论c-myc反义寡核苷酸能显著下调细胞中hTERT基因的表达活性,诱导MCF-7细胞凋亡,并抑制MCF-7细胞生长;在一定程度上,其效果与时间呈正相关。 Objective To investigate the effects of c-myc ASODN on MCF-7 cells growth and the expression of hTERT gene in MCF-7 cells. Methods After transfecting c-myc SODN and ASODN to MCF-7 cells, we measured the proliferation, apoptosis rates and the expression of hTERT mRNA respectively by MTT method, flow cytometry analysis and RT-PCR. Results When c-myc ASODN affected MCR-7 cells at 24h, cells growth was inhibited significantly (P〈0. 05) with hTERT gene expression of MCF-7 cells descending significantly (P〈0. 01). The apoptosis rates of the ASODN-treated cells rised significantly at 48h. The described effects of suppression on cells rised with time increasing. Conclusion c-myc ASODN can effectively inhibit the MCF-7 cells growth, induce apoptosis, and down-regulate hTERT gene expression in MCF-7 cell. The effects correlated with time to a degree.
出处 《肿瘤防治研究》 CAS CSCD 北大核心 2007年第1期14-17,共4页 Cancer Research on Prevention and Treatment
基金 四川省教育厅自然基金重点资助项目(2002A068)
关键词 乳腺肿瘤 c-myc 人端粒酶逆转录酶 反义核酸 MCF-7细胞 Breast neoplasms c-myc Human telomerase reverse transcriptase Antisense Oligonucleotide MCF-7 cell
  • 相关文献

参考文献14

  • 1Perry PJ, Amold JR, Jenkins TC, et al. Telomerase inhibitorsfor the treatment of cancer., the current perspective [J]. ExpertOpin investing Drugs, 2001,10(12): 1241-1256.
  • 2Kirkpatrick KL,Mokbel K.The significance of human telomer ase reverse transcriptase (hTERT) in cancer[J].Eur J Surg Oncol,2001,27(8):754-760.
  • 3Rothermund K,Rogulski K,Fernandes E,et al.C Myc-inde pendent restoration of multiple phenotypes by two C-Myc target genes with overlapping functions[J].Cancer Res,2005,65(6):2097-2107.
  • 4O'Connell BC,Cheung AF,Simkevich CP,et al.A large scale genetic analysis of c-myc regulated gene expression patterns[J].J Biol Chem,2003,278(14):12563-12573.
  • 5Oh S,Song YH,Kim UJ,et al.In vivo and in vitro analyses of Myc for differential promoter activities of the human telomerase (hTERT) gene in normal and tumor cells[J].Biochem Biophys Res Comun,1999,263 (2):361-365.
  • 6Kirkpatrick KL,Ogunkolade W,Elkak AE,et al.hTERT expression in human breast cancer and non-cancerous breast tissue:correlation with tumour stage and c-Myc expression[J].Breast Cancer Res Treat,2003,77 (3):277-284.
  • 7张莉娟,税青林,何国平,赵小平,马莉,彭春.脂质体介导反义核酸对乳腺癌MCF-7细胞增殖的影响[J].中国应用生理学杂志,2005,21(3):338-339. 被引量:1
  • 8Cerni C.Telomeres,telomerase,and myc.An update[J].Mutat Res,2000,462 (1):31-47.
  • 9Kondo Y,Koga s,Komata T,et al.Treatment of prostate cancer in vitro and in vivo with 2-5-anti-telomerase RNA component[J].Oncogene,2000,19(18):2205-2211.
  • 10林勇,谢渭芬,陈伟忠,张新,张兴荣,张忠兵,沈建伟.c-myc调节人端粒酶逆转录酶(htert)启动子活性的体外研究[J].中国肿瘤生物治疗杂志,2001,8(1):34-36. 被引量:10

二级参考文献12

  • 1Manninen I H, Maekinen K. Gene Therapy Techniques for Peripheral Arterial Disease [ J ]. Cardiovasc Intervent Radiol,2002, 25: 98-108.
  • 2Toshikuni N, Nouso K, Higashi I, et al. Expression of telomerase-associated protein and telomerase reverse transcriptase in hepatocellular carcinoma[J]. Br J Cancer, 2000, 82(4): 833-837.
  • 3lord R V, Salonga D, Daneberge K D, et al. Telomerase reverse transcriptase expression is increased early in the Barrett's metaplasia, dysplasia, adenocarcinoma sequence [ J ]. J Gastrointest Surg, 2000, 4(2): 135-142.
  • 4Koanagi Y, Kabayashi D, Ysjima T, et al. Telomerase activity is down regulated via decreases in hTERT mRNA but not TEP1Mma or Htere during the differentiation of leukemic cells[J]. Anticancer Res, 2000, 20(2A): 773-778.
  • 5Cong Y S, Wen J, Bacchetti S. The human telomerase cataly-ticsubunit hTERT: organization of the gene and characerization of the promoter[J]. Hum Mol Genet, 1999, 8: 137-142.
  • 6Oh S, Song YH, Kim UJ, et al. In vivo and in vitro analyses of myc for differential promoter activities of the human telomerase ( htert )gene in normal and tumor cells. Biochem Biophys Res Commun,1999, 63(2):361
  • 7Meyerson M, Counter CM, Eatou EN, et al. hEST2, the putative human telomerase catalytic subunit gene,is up-regulated in tumor cells and during immortalization. Cell, 1997,90:785
  • 8Wu K J, Grandori C, Amacker M, et al. Direct activation of TERT transcription by c-myc. Nat C enet, 1999, 21(2):220
  • 9Klingelhutz AJ. Telomerase activation and cancer. J Mol Med, 1997,75:45
  • 10Dome JS, Look AT. Three molecular determinants of malignant conversion and their potential as therapeutic targets. Curr Opin Oncol,1999,11:58

共引文献9

同被引文献35

引证文献4

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部